Correlation Between Cimpress and Cardlytics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cimpress and Cardlytics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cimpress and Cardlytics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cimpress NV and Cardlytics, you can compare the effects of market volatilities on Cimpress and Cardlytics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cimpress with a short position of Cardlytics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cimpress and Cardlytics.

Diversification Opportunities for Cimpress and Cardlytics

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cimpress and Cardlytics is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Cimpress NV and Cardlytics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardlytics and Cimpress is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cimpress NV are associated (or correlated) with Cardlytics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardlytics has no effect on the direction of Cimpress i.e., Cimpress and Cardlytics go up and down completely randomly.

Pair Corralation between Cimpress and Cardlytics

Given the investment horizon of 90 days Cimpress NV is expected to under-perform the Cardlytics. But the stock apears to be less risky and, when comparing its historical volatility, Cimpress NV is 2.1 times less risky than Cardlytics. The stock trades about 0.0 of its potential returns per unit of risk. The Cardlytics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  370.00  in Cardlytics on September 17, 2024 and sell it today you would earn a total of  0.00  from holding Cardlytics or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cimpress NV  vs.  Cardlytics

 Performance 
       Timeline  
Cimpress NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cimpress NV has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Cimpress is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Cardlytics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cardlytics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating essential indicators, Cardlytics may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cimpress and Cardlytics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cimpress and Cardlytics

The main advantage of trading using opposite Cimpress and Cardlytics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cimpress position performs unexpectedly, Cardlytics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardlytics will offset losses from the drop in Cardlytics' long position.
The idea behind Cimpress NV and Cardlytics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges